Pharmakon Enjoined From OTC Product Sale Following cGMP Noncompliance
This article was originally published in The Tan Sheet
Executive Summary
Pharmakon Labs is permanently enjoined from manufacturing and distributing drugs until the company is in compliance with cGMPs, according to a court order announced by FDA July 27